In-silico Studies and Antioxidant and Neuroprotective Assessment of Microencapsulated Celecoxib against Scopolamine-induced Alzheimer's Disease

Rajendra Herur Vishnumurthy,M. Gnana Ruba Priya,Prashant Tiwari,Viswas Raja Solomon
DOI: https://doi.org/10.2174/0113816128298289240723103828
IF: 3.31
2024-09-03
Current Pharmaceutical Design
Abstract:CONCLUSION: In addition to that, histopathological examination of the hippocampus part showed remarkable improvement in brain cells. So, the findings of the results revealed that MCXB, in a dose-dependent manner, showed a neuroprotective effect against scopolamine-induced AD. This effect may be attributed to the activation of cholinergic pathways.
pharmacology & pharmacy
What problem does this paper attempt to address?